Molecular Basis of Pediatric Liver Cancer
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
The purpose of this retrospective and prospective project is to understand the molecular and genetic basis of liver cancer of childhood. Understanding the molecular and genetic bases of liver cancers can offer a better classification based on tumor biology, mechanisms and predisposition.
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Dziecko leczył się lub leczy się z powodu nowotworu wątroby (złośliwego lub łagodnego) przed ukończeniem 21 lat
- •Biologiczni rodzice dziecka
- •Rodzeństwo dziecka (biologiczne)
✗ Disqualifies
- •Dziecko nigdy nie miało nowotworu wątroby lub go nie leczyło
- •Osoby prawnie opiekujące się dzieckiem (nie biologiczni rodzice)
- •Przyrodnie lub przybrane rodzeństwo
Simplified criteria — AI translation
Trial details
- Minimum age
- 0 Years
- Maximum age
- 99 Years
- Last updated (source)
- August 10, 2026
- Sex
- No restrictions
Locations (1)
UPMC Children's Hospital of Pittsburgh
Pittsburgh, United States
Trial contact
Morgan Paul, BSN
Daniel Pieratt, MPA
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 8/11/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.